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Abstract
Introduction: Burkitt lymphoma and B cell lymphomas in childhood may arise in many atypical
locations, which on rare occasions can include gastric mucosa. A case of primary gastric Burkitt
lymphoma is described in a child presenting as a protein-losing enteropathy, including the direct
monitoring of the disease response by sequential endoscopic biopsy and molecular analysis.
Case presentation: We report a 9-year-old boy who presented with gross oedema, ascites and
respiratory distress caused by a protein-losing enteropathy. Initial imaging investigations were non-
diagnostic but gastroduodenal endoscopy revealed massive involvement of the gastric mucosa with a
primary Burkitt lymphoma. His subsequent clinical progress and disease response were monitored
directly by endoscopy and he remains in clinical remission 4 years after initial diagnosis.
Conclusions: This is the first case report of primary Burkitt lymphoma presenting as a protein-
losing enteropathy. The clinical course and progress of the patient were monitored by sequential
endoscopic biopsy, histology and molecular analysis by fluorescence in situ hybridisation.
Introduction
Protein-losing enteropathy (PLE) has many causes includ-
ing gastrointestinal lymphoma [1-3], however, there are
no reports of protein-losing enteropathy caused by a
primary gastric lymphoma in childhood. Here we report
theclinical presentation, endoscopic features and outcome
of a child with PLE caused by Burkitt lymphoma of the
stomach.
Case presentation
A previously healthy 9-year-old boy with normal growth
and development presented with progressive pallor,
peripheral oedema and respiratory distress. Examination
showed pallor, pitting oedema, and respiratory distress.
No lymphadenopathy, jaundice, hepatosplenomegaly or
abdominal masses were present, and the remainder of the
physical examination was normal.
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and total protein 27 g/L, with normal liver and renal
function. The urine was normal with no proteinuria or
haematuria. Haemoglobin (Hb) was 89 g/L, white blood
cell count (WCC) 16.6 × 10
9/L, but neutrophils and
lymphocytes and blood film were normal.
The chest X-ray (CXR) showed consolidation in the right
lower lobe and an abdominal ultrasound scan was normal.
At gastroduodenal endoscopy, multiple raised large (2 to
3 cm in diameter) ulcerated tumours of the greater
curvature of the gastric body were seen (Figure 1), and
numerous smaller tumours were seen in the second and
third part of the duodenum but colonoscopy was normal.
Computed tomography (CT) of the chest and abdomen
showed multiple exophytic lesions in the stomach, several
filling defects within the jejunum, and a 5 cm long
intussusception in the ileum (Figure 2). Small lymph
nodes were seen around the superior mesenteric vessels.
Bilateral pleural effusions and atelectasis were seen in the
chest but there was no mediastinal lymphadenopathy.
Gastric biopsies showed a diffuse lymphoid infiltrate
(Figure 3A), immunohistochemistry identified a B-cell
population and flow cytometry was positive for the B-cell
markers CD20, CD10 and CD43 (Figure 3B). Fluorescence
in situ hybridisation (FISH) was positive for the C-MYC,
t(8:14) translocation of Burkitt lymphoma. The bone
marrow aspirate, trephine biopsy and cerebrospinal fluid
(CSF) were normal. No Helicobacter pylori infection was
detected.
The histology, immunophenotype and FISH analysis of the
biopsies, and the radiological findings were consistent with
a primary gastrointestinal Burkitt lymphoma, Stage III,
Group B.
Treatment was according to the UKCCSG consensus
guideline for Burkitt lymphoma (2003). Induction che-
motherapy with cyclophosphamide, vincristine and pre-
dnisone (COP) was given together with alkaline hydration
and allopurinol, daily albumin infusions, frusemide and
omeprazole.
No tumour lysis syndrome occurred, and there was a rapid
rise in serum albumin and protein with resolution of
clinical signs of protein-losing enteropathy.
Further chemotherapy included two courses of cyclopho-
sphamide, vincristine, prednisone, cytarabine, doxorubicin
and methotrexate (COPADAM) followed by two courses of
Figure 1. Gastric endoscopy. (A, B) Gastric body tumours;
multiple large (2 to 3 cm in diameter) raised ulcerated
tumours involving the greater curvature of the gastric body
and numerous smaller tumours in the second and third part of
the duodenum, as far as the gastroscope could reach. (C)
Gastric body tumour after 1 week of chemotherapy. (D)
Gastric body tumour after 5 months of chemotherapy
demonstrating complete resolution of the lymphomatous
masses with only residual scaring present.
Figure 2. Computed tomography scan of the abdomen at
diagnosis. Exophytic masses with multiple filling defects are
present in the gastric mucosa.
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chemotherapy of methotrexate and hydrocortisone.
Our patient’s clinical course and disease response were
monitored by sequential endoscopic biopsy, histology
and molecular analysis by FISH. The rapid clinical
response was reflected in the rapid histological and
molecular resolution of disease. Follow-up endoscopy
showed complete resolution of the mucosal tumours with
only residual mucosal puckering present. Abdominal CT
cans were normal and, once in remission and having
completed chemotherapy, the patient’s ongoing disease
surveillance was by endoscopy and repeat biopsy for FISH
analysis. No molecular evidence of residual disease was
detected, and he remains in clinical remission with
complete resolution of the protein-losing enteropathy
and no treatment related sequelae 4 years from initial
diagnosis.
Discussion
Lymphoma is a well-known cause of protein-losing
enteropathy in adults. However, in most cases, it is caused
by either diffuse nodal infiltration obstructing intestinal
lymphatics or a primary mucosal lymphoma located more
distally in the small intestine [1-3]. However, primary
gastric lymphoma is rare in the paediatric population, and
most of these cases have been associated with gastro-
intestinal symptoms such as pain, dysphagia, bleeding or
gastric outlet obstruction [4-10].
Several cases of primary gastric lymphoma have been
described in children in association with concomitant
Helicobacter pylori infection. Blecker et al. described a single
case of mucosa-associated lymphoid tissue (MALT) lym-
phoma more commonly found in adults in a 14-year-old
girl with a history of H. pylori associated chronic gastritis
[11]. More recently, Mezlini et al. described two further
cases of MALT lymphomas in children with concomitant
H. pylori infection [12]. These children presented with
similar clinical features to those seen in adults.
We report the endoscopic findings of primary gastric
Burkitt lymphoma in childhood presenting as a protein-
losing enteropathy. The diagnosis here was made difficult
by the absence of chronic or acute gastrointestinal
symptoms and initial imaging studies also did not indicate
a likely aetiology. It was only on endoscopy that other
more common causes such as primary intestinal lym-
phangiectasia, inflammatory diseases and infection were
excluded. Here, gastroduodenal endoscopy provided an
accurate diagnosis and staging, and was the most useful
modality in monitoring the response to treatment.
Burkitt and B-cell lymphomas in childhood have an
excellent overall prognosis regardless of the location
(except for primary central nervous system (CNS) lym-
phoma), especially when treated with contemporary
chemotherapy protocols [13].
Conclusion
Primary Burkett lymphoma of the gastric mucosa is
uncommon in childhood. We report a child presenting
with a protein-losing enteropathy whose subsequent
clinical course was monitored by sequential endoscopic
biopsy and molecular analysis by FISH. The clinical
outcome for Burkitt lymphoma in childhood is excellent,
even when presenting in unusual sites with rare clinical
manifestations.
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